Metastatic Malignant Neoplasm in the Peritoneum Clinical Trials

9 clinical trials for Metastatic Malignant Neoplasm in the Peritoneum across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases — RECRUITING · PHASE1
• PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer — RECRUITING · PHASE1
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer — RECRUITING · PHASE1
• Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study — RECRUITING · PHASE2
• Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis — RECRUITING · PHASE2
• Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases — RECRUITING · PHASE1
• Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis — ACTIVE_NOT_RECRUITING · PHASE1
• Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial — NOT_YET_RECRUITING · PHASE3

Refine this search